Discuss This Drug

bimatoprost

CHEBI:CHEBI_51230

Chemical Information

Molecular Formula
C25H37NO4
Molecular Mass
415.56562
Charge
0
SMILES
CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCc1ccccc1
InChI
InChI=1S/C25H37NO4/c1-2-26-25(30)13-9-4-3-8-12-21-22(24(29)18-23(21)28)17-16-20(27)15-14-19-10-6-5-7-11-19/h3,5-8,10-11,16-17,20-24,27-29H,2,4,9,12-15,18H2,1H3,(H,26,30)/b8-3-,17-16+/t20-,21+,22+,23-,24+/m0/s1
InChIKey
AQOKCDNYWBIDND-FTOWTWDKSA-N

Alternative Names

  • (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenylpent-1-en-1-yl]cyclopentyl}-N-ethylhept-5-enamide
  • (Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1E,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide
  • bimatoprost
  • bimatoprost
  • bimatoprostum

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

DRON_00010000
283810
oboInOwl#hasDbXref
KEGG:D02724
core#notation
CHEBI:51230

Additional References

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

listing_expiration_date
20241231
marketing_start_date
20010316
route
INTRACAMERAL
labeler_name
NEWCHEM SPA
spl_id
60f622b2-05f8-729c-e053-2a91aa0ae83a
package_ndc
68083-296-01
package_description
1 BOTTLE in 1 CARTON (68083-296-01) / 5 mL in 1 BOTTLE
oboInOwl#hasOBONamespace
chebi_ontology
DRON_00010000
283810
generic_name
Bimatoprost A Form
brand_name
DURYSTA
brand_name_base
DURYSTA
oboInOwl#hasDbXref
KEGG:D02724
oboInOwl#id
CHEBI:51230
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
dosage_form
IMPLANT
product_ndc
68083-296
application_number
ANDA202719
RO_0000087
http://purl.obolibrary.org/obo/CHEBI_35674
oboInOwl#inSubset
http://purl.obolibrary.org/obo/chebi#3_STAR
rxcui
2286607
manufacturer_name
Somerset Therapeutics, LLC
package_marketing_start_date
09-JUL-12
unii
QXS94885MZ
core#notation
CHEBI:51230
active_ingredient_strength
.2 g/.2g
pharm_class_epc
Prostaglandin Analog [EPC]
pharm_class
Prostaglandins [CS]
pharm_class_cs
Prostaglandins [CS]
active_ingredient_name
BIMATOPROST
nui
M0017805
spl_set_id
27bef7e1-750a-4ac1-ab5f-e4c0121ffcbc
upc
0342571128289
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
has_treatment
http://purl.obolibrary.org/obo/DOID_0060968
rdf-schema#domain
https://w3id.org/def/predibionto#has_side_effect27785
owl#annotatedSource
t242061
owl#someValuesFrom
t666092